Second-line olaparib maintenance therapy is associated with poor response to subsequent chemotherapy in BRCA1/2-mutated epithelial ovarian cancer: A multicentre retrospective study
Junsik Park, Se Ik Kim, Soo Jeong, Yup Kim, Michael A. Bookman, Jae‐Weon Kim, Byoung‐Gie Kim, Jung‐Yun Lee
Topics & Concepts
OlaparibMedicineOncologyInternal medicineMaintenance therapyBRCA mutationChemotherapyPost-hoc analysisOvarian cancerCancerBiologyPoly ADP ribose polymeraseBiochemistryGenePolymerasePARP inhibition in cancer therapyOvarian cancer diagnosis and treatmentAdvanced Breast Cancer Therapies